Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0677481 (
urinary frequency
)
1,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Interstitial cystitis is a disease of unknown etiology characterized by unremitting
urinary frequency
, urgency and suprapubic pain. Recently, a change in urothelial permeability has been identified in interstitial cystitis patients that is presumably mediated by aberrations in bladder surface mucin. For this study we evaluated qualitative changes in a previously defined glycoprotein component of this layer (
GP1
) as it occurs in interstitial cystitis patients and normal controls. Paraffinized bladder biopsies were obtained from 23 interstitial cystitis patients (all meeting National Institutes of Health inclusion criteria) and 11 normal controls. All biopsy tissue was stained with hematoxylin and eosin, and periodic acid, Schiff reaction. The tissues were examined immunohistochemically for
GP1
using an anti-
GP1
serum. Periodic acid, Schiff staining clearly identified bladder surface proteoglycans in all specimens. Moderate
GP1
reactivity was noted in all normal control specimens. Alternatively,
GP1
expression was absent in 35% of the interstitial cystitis patient biopsies and decreased in 61%. These data demonstrate qualitative
GP1
changes in a majority of interstitial cystitis patients. It is unknown whether these differences have an impact on the pathogenesis of interstitial cystitis. However, our findings suggest that the absence or decreased expression of
GP1
in interstitial cystitis bladder biopsies may serve as a marker to characterize the disease further in conjunction with clinical findings.
...
PMID:Decreased expression of a glycoprotein component of bladder surface mucin (GP1) in interstitial cystitis. 828 23